<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5653">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01110252</url>
  </required_header>
  <id_info>
    <org_study_id>upeclin/ASSIS Unesp - 001</org_study_id>
    <nct_id>NCT01110252</nct_id>
  </id_info>
  <brief_title>Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease</brief_title>
  <acronym>COPD-01</acronym>
  <official_title>Unicentric Study Protocol of Cell Therapy in Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UPECLIN HC FM Botucatu Unesp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratório de Genética Humana e Terapia Celular, Unesp - Assis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto de Molestias Cardiovasculares</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>UPECLIN HC FM Botucatu Unesp</source>
  <oversight_info>
    <authority>Brazil: National Committee of Ethics in Research</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the cell therapy with bone marrow
      mononuclear cells is safe in the treatment of chronic obstructive pulmonary disease,
      specifically the pulmonary emphysema.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main feature of the pulmonary emphysema, included in range of the Chronic Obstructive
      Pulmonary Disease (COPD), is the airflow obstruction resulting from the destruction of the
      alveolar walls distal to the terminal bronchiole, without significant pulmonary fibrosis.
      The existing clinical approaches has contributed to the enlargement and amelioration of the
      emphysema patients life quality, although no effective or curative treatment has been
      achieved. The surgical treatment, on the other hand, involves complex procedures and, in the
      specific case of lung transplantation, a lack of donors.

      Considering these aspects, several experimental models have been proposed aiming to increase
      knowledge about the pathophysiological processes and enable new clinical approaches to the
      pulmonary emphysema. The cell therapy, briefly described as the use of cells in disease
      treatment, presents itself as a promising therapeutic approach with great potential
      applicability in degenerative pulmonary diseases. In this way, it is intended in this
      project, the proposition of a protocol to evaluate the safety of cell therapy with pool of
      mononuclear cells from bone marrow in patients with clinical and laboratory diagnosis of
      pulmonary emphysema in advanced stage (stage IV dyspnea).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Forced Vital Capacity (FVC)</measure>
    <time_frame>baseline and 30 days after procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>A pulmonary function test that measures the volume and speed of the inhalated air.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forced Expiratory Volume (FEV1)</measure>
    <time_frame>baseline and 30 days after procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>A pulmonary function test that measures the volume and speed of the exhaled air.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vital Capacity - VC</measure>
    <time_frame>baseline and 30 days after the procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>A pulmonary function test that measures the volume and speed of the inhalated and exhaled air.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial Blood Gases Test - Pa O2</measure>
    <time_frame>baseline and 30 days after procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>presence of oxygen in the blood gases.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial Blood Gases Test - Pa CO2</measure>
    <time_frame>baseline and 30 days after the procedure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>presence of CO2 in the arterial blood.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Pulmonary Emphysema</condition>
  <arm_group>
    <arm_group_label>pre-procedure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>emphysema patients evaluated prior to the stem cells infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>post-procedure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>emphysema patients evaluated 30 days after the stem cells infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Stem cells stimulation</intervention_name>
    <description>Subcutaneous injection of 5mcg/kg of G-CSF 3 days before the procedure.</description>
    <arm_group_label>pre-procedure</arm_group_label>
    <arm_group_label>post-procedure</arm_group_label>
    <other_name>Filgrastin - ACHÉ Laboratories.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>stem cells collection</intervention_name>
    <description>pullout of 200ml of bone marrow through the puncture of the iliac crest</description>
    <arm_group_label>pre-procedure</arm_group_label>
    <arm_group_label>post-procedure</arm_group_label>
    <other_name>bone marrow harvest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>stem cells infusion</intervention_name>
    <description>slow infusion through the brachial vein of 30ml of bone marrow mononuclear cells diluted in albuminous saline.</description>
    <arm_group_label>pre-procedure</arm_group_label>
    <arm_group_label>post-procedure</arm_group_label>
    <other_name>adult stem cell infusion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of severe chronic obstructive pulmonary disease

          -  ineffective clinical treatment

          -  limited life expectancy

          -  limitations in daily physical activity

          -  possibility of pulmonary rehabilitation physiotherapy

          -  acceptable nutritional status

          -  acceptable cardiac function

          -  at least six months smoking cessation

          -  family support

          -  modified medical research council dyspnea scale stage &gt; 3

        Exclusion Criteria:

          -  pulmonary or extra-pulmonary infection

          -  severe coronary disease and/or ventricular dysfunction

          -  significant kidney or liver disease

          -  immunosuppressive disease

          -  active smoker

          -  cancer

          -  psychosocial problems

          -  established medical protocol

          -  family rejection

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>72 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>João T Ribeiro-Paes, PhD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>geneticist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aldemir Bilaqui, MD</last_name>
    <role>Study Director</role>
    <affiliation>surgeon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oswaldo T Greco, MD</last_name>
    <role>Study Chair</role>
    <affiliation>cardiologist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Milton A Ruiz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>hematologist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José D Araújo, MD</last_name>
    <role>Study Chair</role>
    <affiliation>surgeon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mario R Lago, Ms</last_name>
    <role>Study Chair</role>
    <affiliation>technician</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laboratório de Genética Humana e Terapia Celular</name>
      <address>
        <city>Assis</city>
        <state>São Paulo</state>
        <zip>19.806-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <lastchanged_date>February 22, 2012</lastchanged_date>
  <firstreceived_date>April 20, 2010</firstreceived_date>
  <firstreceived_results_date>November 3, 2011</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UPECLIN HC FM Botucatu Unesp</investigator_affiliation>
    <investigator_full_name>João Tadeu Ribeiro Paes</investigator_full_name>
    <investigator_title>sponsor</investigator_title>
  </responsible_party>
  <keyword>Chronic Obstructive Pulmonary Disease</keyword>
  <keyword>Emphysema</keyword>
  <keyword>Cell therapy</keyword>
  <keyword>Bone marrow mononuclear cells</keyword>
  <keyword>stem cells</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Pulmonary Emphysema</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From May 2009 to October 2009 four patients with clinical and laboratory diagnosis for advanced pulmonary emphysema were enrolled</recruitment_details>
      <pre_assignment_details>Patients signed the Knowledge and Free Consent Instrument (TCLE)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Prior Then Post Procedure (Stem Cells Infusion)</title>
          <description>emphysema patients evaluated prior or after the infusion of the autologous stem cells</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Pre-procedure (Stem Cells Infusion)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Post-procedure (Stem Cells Infusion)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Prior Then Post Procedure (Stem Cells Infusion)</title>
          <description>emphysema patients evaluated prior or after the infusion of the autologous stem cells</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="65.75" spread="1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Brazil</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Forced Vital Capacity (FVC)</title>
        <description>A pulmonary function test that measures the volume and speed of the inhalated air.</description>
        <time_frame>baseline and 30 days after procedure</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>all patients were evaluated prior and after the procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Prior to the Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated prior to the infusion of autologous stem cells</description>
          </group>
          <group group_id="O2">
            <title>Post Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated 30 days after the infusion of autologous stem cells</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Forced Vital Capacity (FVC)</title>
            <description>A pulmonary function test that measures the volume and speed of the inhalated air.</description>
            <units>liters</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="0.2"/>
                  <measurement group_id="O2" value="2.1" spread="0.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Forced Expiratory Volume (FEV1)</title>
        <description>A pulmonary function test that measures the volume and speed of the exhaled air.</description>
        <time_frame>baseline and 30 days after procedure</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>all patients were evaluated prior and after the procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Prior to the Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated prior to the infusion of autologous stem cells</description>
          </group>
          <group group_id="O2">
            <title>Post Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated 30 days after the infusion of autologous stem cells</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Forced Expiratory Volume (FEV1)</title>
            <description>A pulmonary function test that measures the volume and speed of the exhaled air.</description>
            <units>liters</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="0.1"/>
                  <measurement group_id="O2" value="0.8" spread="0.1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arterial Blood Gases Test - Pa O2</title>
        <description>presence of oxygen in the blood gases.</description>
        <time_frame>baseline and 30 days after procedure</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>all patients were evaluated prior and after the procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Prior to the Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated prior to the infusion of autologous stem cells</description>
          </group>
          <group group_id="O2">
            <title>Post Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated 30 days after the infusion of autologous stem cells</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Arterial Blood Gases Test - Pa O2</title>
            <description>presence of oxygen in the blood gases.</description>
            <units>mmHg</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="69" spread="3"/>
                  <measurement group_id="O2" value="57" spread="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Arterial Blood Gases Test - Pa CO2</title>
        <description>presence of CO2 in the arterial blood.</description>
        <time_frame>baseline and 30 days after the procedure</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>all patients were evaluated prior and after the procedure</population>
        <group_list>
          <group group_id="O1">
            <title>Prior to the Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated prior to the infusion of autologous stem cells</description>
          </group>
          <group group_id="O2">
            <title>Post Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated 30 days after the infusion of autologous stem cells</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Arterial Blood Gases Test - Pa CO2</title>
            <description>presence of CO2 in the arterial blood.</description>
            <units>mm Hg</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="48.75" spread="2.7"/>
                  <measurement group_id="O2" value="89.25" spread="2.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Vital Capacity - VC</title>
        <description>A pulmonary function test that measures the volume and speed of the inhalated and exhaled air.</description>
        <time_frame>baseline and 30 days after the procedure</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>all patients were evaluated prior and after the procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Prior to the Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated prior to the infusion of autologous stem cells</description>
          </group>
          <group group_id="O2">
            <title>Post Procedure (Stem Cells Infusion)</title>
            <description>emphysema patients evaluated 30 days after the infusion of autologous stem cells</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                  <measurement group_id="O2" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Vital Capacity - VC</title>
            <description>A pulmonary function test that measures the volume and speed of the inhalated and exhaled air.</description>
            <units>liters</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="0.3"/>
                  <measurement group_id="O2" value="1.4" spread="0.3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Prior Then Post Procedure (Stem Cells Infusion)</title>
          <description>emphysema patients evaluated prior or after the infusion of the autologous stem cells</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>small number of subjects analyzed</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>João Tadeu Ribeiro Paes</name_or_title>
      <organization>Labcel</organization>
      <phone>55 18 3302 5800 ext 5856</phone>
      <email>labcel.tronco@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
